New research from the FLASH registry (ClinicalTrials.gov identifier: NCT03761173) shines a light on the effectiveness of large-bore mechanical thrombectomy in managing high-risk pulmonary embolism.

PHOENIX -- Hemodynamic and symptomatic benefits of mechanical thrombectomy for acute intermediate- to high-risk pulmonary embolism (PE) persisted to 6 months, the FLASH registry showed. Right ...

The use of mechanical thrombectomy (MT) was associated with reduced major adverse events in the short term and improved quality of life in the long term for pulmonary embolism (PE) patients with ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Large-bore mechanical thrombectomy for pulmonary ...

HENDERSONVILLE, Tenn. (WSMV) - TriStar Hendersonville Medical Center announced the hospital’s first successful pulmonary thrombectomy. A pulmonary thrombectomy is a procedure that removes blood clots ...

Please provide your email address to receive an email when new articles are posted on . Among patients with pulmonary embolism who underwent percutaneous thrombectomy, women experienced more procedure ...

WASHINGTON, DC — Large-bore mechanical thrombectomy is superior to catheter-directed thrombolysis for pulmonary embolism, according to a randomized trial comparing the two interventions. Although ...

June Hoffman's shortness of breath snuck up on her. It started in the morning, hardly noticeable as she got dressed for a routine visit to her rheumatologists office. But by the time she reached the ...

CAMPBELL, Calif., September 17, 2025--(BUSINESS WIRE)--Imperative Care, Inc. today announced positive efficacy and safety results from the pivotal SYMPHONY-PE Trial (NCT06062329) evaluating the ...

The patient was a 660 g African-American male born at 26 weeks' gestation via urgent caesarian section for preterm labor and breech presentation. The mother was a 33-year-old gravida 4 para 2 woman.

Imperative Care announced today that it enrolled the first patient in the CLEAR-IT study evaluating its Symphony and Prodigy ...